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1. Introduction 
The leukotrienes constitute a new group of biolog- 
ically active compounds derived from polyunsatu- 
rated fatty acids [ 11. Thus, arachidonic acid can be 
oxygenated by a lipoxygenase to SS-hydroperoxy- 
eicosatetraenoic acid [2], which is further converted to 
an unstable epoxide, 5,6-oxido-7,9,11,14-eicosatetra- 
enoic acid (leukotriene Aq, LTA4) [3,4]. This inter- 
mediate is transformed enzymatically by addition of 
glutathione into a ‘slow-reacting substance of anaphy- 
laxis’ (SRS-A), LTC4 [5,6]. The biological activity of 
most SRS-A preparations is due to LTC4 and the two 
metabolites LTD4 and LTE4 [7-91. 
LTA4 can also be hydrolyzed enzymatically to 
5S,12R-dihydroxy-6-cis,8,1O-trans,l4-cis-eicosatetra- 
enoic acid (LTB4) [ 1 O-l 2] or non-enzymatically to 
isomeric 5,12- and 5,6-dihydroxy-eicosatetraenoic 
acids [ 131. We have reported the formation of a novel 
dihydroxy-acid, 5S,12S-dihydroxy-6-trans,8-cis,lO- 
trans,l4-cis-eicosatetraenoic acid (SS,12SDHETE), in 
preparations of human leukocytes [ 14). This dihy- 
droxy-acid was not formed via an epoxide intermedi- 
ate, but by a double oxygenation of arachidonic acid. 
In addition, an w-hydroxylated metabolite, 5S,12S,20- 
trihydroxy-6-trans,8-cis,lO-trarzs,lLF-cis-eicosatetra- 
enoic acid (5S,12S,20-THETE), was identified. 
This report describes the formation of an w-hydrox- 
ylated metabolite of LTB4, 5S,12R,20-trihydroxy-6- 
cis$,lO-trans,l4&s-eicosatetraenoic acid (20-OH- 
LTB4) in human leukocyte preparations and further 
conversion of this trihydroxy acid to a dicarboxylic 
acid (20-COOH-LTB4). In addition, the biological 
activity of LTB4, 20-OH-LTB4 and 20-COOH-LTB4, 
on guinea pig lung strips is reported. 
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2. Materials and methods 
2.1. Cell preparation and incubations 
Human leukocyte suspensions (60 X 1 O6 white 
cells/ml phosphate-buffered saline containing 0.87 mM 
CaClz (pH 7.4)) were prepared as in [ 151. The suspen- 
sions (100 or 200 ml) were warmed to 37°C and 
incubated for 10 min with 5 PM ionophore A23 187 
(Calbiochem-Behring, La Jolla CA) and 150 PM 
arachidonic acid (Nu-Check Prep., Elysian MN). The 
incubations were stopped by addition of 3 ~01s. etha- 
nol. Incubations under ‘so2 atmosphere were carried 
out as in [ 141. 
2.2. Purification and analytical methods 
Purification of the products was performed as in 
[ 141. This implies ether extraction, silicic acid chro- 
matography, reverse phase (RP-) and straight phase 
(SP-) high-performance liquid chromatography 
(HPLC). Gas chromatography-mass spectrometry 
(CC/MS) of trimethylsilyl ether methyl esters of 
hydrogenated and non-hydrogenated compounds and 
oxidative ozonolysis using (-)-menthoxycarbonyl 
derivatives were done as in [ 141. 
2.3. Bioassay 
Guinea pig subpleural parenchymal strips (length 
-25 mm, cross-sectional area -7.5-10 mm”) were 
suspended in 5 ml organ baths filled with Tyrode’s 
solution. Contractions were recorded isometrically at 
a resting tension of 2.5 mN and expressed as % of 
maximal response induced by 100 PM histamine and 
40 mM KCl. Before bioassay methyl esters of the 
leukotrienes tested were hydrolyzed (using 0.1 M 
LiOH in tetrahydrofurane; 23”C, 18 h) and purified 
on RP-HPLC. 
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3 _ Results 
Human leukocytes were incubated with ionophore 
A23 187 and arachidonic acid. Products were purified 
by ether extraction, sihcic acid chromatography and 
BP-HPLC. The BP-HPLC chromatogram was similar 
to those obtained in this system [ 11,14], with the 
main dihydroxyiated products SS,i 2S-DHETE and 
LTB4 cochromatographing in one peak eluted after 
40 min. In addition a major polar peak with a reten- 
tion time of 12 min was found (cf [ 141). This mate- 
rial was converted to methyl esters with diazometh- 
ane and subjected to SP-HPLC (fig.1). We have 
recently identified one of the two major products, 
compound C, as SS,12S,20-trihydroxy-6-trans,8- 
cis,lO-trans,l4&-eicosatetraenoic acid (5S,12S,20- 
THETE) [ 141. The other main product, compound D, 
showed a ~-spectrum (absorption maxima at 260, 
270 and 281 nm) almost identical to that of LTB4 
I 
20 
f / / I 
30 40 50 60 
Elution time (min) 
Fig.1, Curve @ shows a SP-HPLC chromatogram of the 
methyi esters of the polar products isolated from human leu- 
kocyte suspensions after incubation with ionophore A23187 
and arach~dorr~c acid. Curves @ - @ show corresponding 
chromatogram obtained after incubation of human leukocyte 
preparations with LTB,, 5S,12S-DHETE and ZO-OH-LTB,, 
respectively. 
but shifted bathochromically 2 nm compared to that 
of compound C. Gas chromatography of the tri- 
methylsilyl ether methyl ester of compound D 
showed a peak with C-value 26.7 (1% SE-30). In the 
mass spectrum (fig.2) prominent ions were found at 
m/e: 582 (M), 567 (M-l 5)? 551 (M-31), 492 (M-90), 
383 (M-l 99, loss of XX--CH=CH-(CH& 
CHaOSiMes), 327,3 17,293 (M-(199 + go)), 267, 
229, 217 (probably Me$iO-CH=CH-CH=O’SiMea 
from a rearrangement), 203 (Me,SiO’=CH-(CH2)s- 
COOCH3 and M-(199 + 90 + 90)), 191 (probably 
Me~SiO~H=O’SiMe~ from a rearrangement) and 129 
(base peak). This indicates that compound D is a 
tetraunsaturated C-20 acid with 3 hydroxylgroups 
located at C-5, C-l 2 and the third at a position 
beyond C-13. The high relative intensity of ions at 
m[e 129,217,267,293 and 383 (cf. fl0,14]) indi- 
cate that the first part of the molecule (C 1 --C-l 2) is 
structuraliy related to LTB, [IO]. The increase in 
C-value for the trimethylsilyl ether methyl ester of 
compound D (C-26.7) compared to the corresponding 
derivative of LTB4 (C-23.6 [lo]) was 3.1 C, suggest- 
ing that the additional hydroxyl group is located at 
the C-20 position [ 16,171. The proposed structure, 
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic a id, 
was further supported by the mass spectrum of the 
trimethylsilyl ether methyl ester of hydrogenated 
compound D (C-value 27.3), which was in agreement 
with the mass spectrum of the same derivative of 
h~~drogenated 55’,12&‘,20-THETE 1141. 
To investigate the mechanism of formation of 
compound D, leukocyte preparations were incubated 
with ionophore A23 187 and arachidonic acid under 
an atmosphere of 1802. The mass spectrum of the 
trimethylsily~ ether methyl ester of compound D 
formed in these experiments contained several ions, 
which were shifted 4 units to higher m/e values 
(m/e 586 (M), 571, 555 and 496), while other ions 
(mfe 385,295, 269,219 and 205) were shifted 
2 units to higher m/e values. These data show that 
compound D carried two atoms of r8O, located at 
C-5 and C-20. This was also confirmed by CC/MS of 
the trimethylsilyl ether methyl ester of hydrogenated 
compound D from the same experiments. The mass 
spectrum contained ions, which were shifted 4 units 
(m/e 579, 563 and 4931, or 2 units (m/e 305,205 
and 105) to higher pnje values. Thus, the Itydroxyl 
groups at C-5 and C-20 were derived from molecular 
oxygen, while the hydroxyl group at C-1 2 was 
derived from water (cf. 13,141). 
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Fig.2. Mass spectrum of the trimethyls~yl ether methyl ester of compound D. 
To establish the position of the double bonds and LTB, or SS,12S,DHETE (10 PM) were incubated 
perform steric analysis of the alcohol groups, the with human leukocyte suspensions (37°C 10 min). 
(-)-menthoxycarbonyl methyl ester of compound D After initial purification, BP-HPLC revealed polar 
was subjected to oxidative ozonolysis. After treat- peaks (retention time 12 min), which were converted 
ment with diazomethane the fragments were analyzed to methyl esters and subjected to SP-HPLC (see fig.1). 
by gas chromatography using a 3% OV-2 10 column. As expected, LTBq gave rise to one single peak, cor- 
The products were shown to cochromatograp~l with responding to compound D, while 5S,I2S-DHETE 
the reference compounds (-~ment~oxycarbonyl was converted to a compound with identical reten- 
dimethyl 2+S-hydroxy adipate and (-)-menthoxycar- tion time as compound C. GCfMS analysis of the 
bony1 dimethyl R-malate. These results demonstrate material confirmed the identity with SS,12R,20- 
that the structure of compound D is SS,12R,20- trihydroxy-6,8,10,14-eicosatetraenoic acid (20.OH- 
trihydroxy-6,8,10,14-eicosatetraenoic acid. LTB4) and 55’,12S,20-THETE, respectively. 
To study the pathway of formation of this tri- In other experiments human leukocyte suspen- 
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Fig.3. Mass spectrum of the trimethyis~yi ether methyl ester of compound E. 
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37’C; 30 min). After ether extraction and silicic acid 
chromatography the products were subjected to 
anion exchange chromatography using dietl~ylamino- 
hydroxypropyl Sephadex LH-20 (DEN-L~~-20) ]I 8]. 
The dicarboxylic fraction from this column was 
extracted at pH 3 with ethyl acetate, converted to 
methyl esters and subjected to SP-HPLC. One major 
peak with the same retention time as compound E 
appeared (fig.1). This material and compound E were 
identical as judged by GC/MS of the trimethylsilyl 
ether methyl ester derivatives showing peaks with 
C-value 26.5. In the identical mass spectra (fig.3) ions 
of high intensity were present at m/e: 538 (M), 523 
{M-IS), 507 (M-31) 448 (M-90) 383 (M-155, loss of 
.C~*-COACH-(CH~)~-COOCH~), 293 (M-(1 55 + 
90)) 267,217,203 (see above), 129 (base peak), 
suggesting a tetraunsaturated C-20 dicarboxylic acid 
with hydroxyl groups at C-5 and C-12. Thus, com- 
pound D can be oxidized by human leukocyte prepa- 
rations to a dioic acid, SS,12R-dihydroxy-6,8,10,14- 
eicosatetraen-1,20-dioic acid (20~COOH-LTB4). 





Fig.4. Non-cumulative dose-response relations for LTB, (*), 
20-01-I-LTB, (A), 20COOH-LTB, (A), LTC, (o) and hista- 
mine (*) in guinea pig lung parenchymal strips. Indicated 
drug concentrations refer to final concentration in bath fluid 
surrounding the tissue. Log dose-response relations for leu- 
kotrienes were established from mean values of4-5 obs. in 
separate tissues at each concentration. Data presented as 
mean t SEM, in percent of maximal concentration. 
20-COOH-LTB4 was compared to that of LTC4 and 
histamine in the guinea pig lung strip. LTB4 and its 
metaboiites caused dose-dependent contractions, 
which were slower in onset and of longer duration than 
responses evoked by equipotent concentrations of 
histamine. However, relative to cysteinyl-containing 
leukotrienes, contractions induced by LTB, or its 
w-oxidized derivatives were short-lived and returned 
to resting tension within 15 min. According to dose- 
response relations assessed non-cumulatively, LTB4, 
20-OH-LTB4 and 20-COOH-LTB4 were >lO-times 
more potent than histamine, although 50-lOO-times 
less active than LTC4 (fig.4) [ 19,201. 
4. Discussion 
Here, we describe the identification of a novel 
wl-hydroxylated metabolite of LTB4, 5S,12R,20- 
trihydroxy-6,8,10,14-eicosatetraenoic acid (20-OH- 
LTB,) isolated from a human leukocyte preparation 
(fig.5). GC/MS- and W-absorbance-data of this polar 
compound indicated that the stereochemistry corre- 
sponded to LTB4 [ 10,11,14]. Steric analysis showed 
that the configuration of the alcohol groups at C-5 
and C-12 was identical to that of LTB4 (i.e., 5S,12R) 
[lo]. As judged by labeling experiments with “02 
the C-5 hydroxyl group was derived from the molecu- 
lar oxygen, while the C-l 2 hydroxyl group was 
formed from water. This indicated the same mecha- 
nism of formation as for LTB,, [3]. Furthermore, 
LTB, could be transformed into compound D by 
human leukocyte preparations. In the same system 
5S,12S-DHETE, was converted to 5S,12S,20-THETE. 
An wl position for the additional hydroxyl group 
in the LTB4 structure was suggested by gas chromato- 
graphic data (increase of C-value with 3.1 [16,17]) , 
and by the finding of a promi~lent ion at m/e 103 in 
the mass spectrum of the trimethyIsiIy1 ether methyl 
ester of hydrogenated compound D. After **O-label- 
ing this ion was shifted to m/e 105, also showing that 
the wl-hydroxyl group was derived from molecular 
oxygen. Additional support for a terminal hydroxyl 
group was obtained by the conversion of com- 
pound D to a dicarboxylic acid, SS,12R-dihydroxy- 
6,8,10,14-eicosatetraen-1,20-dioic a id (20~COOH- 
LTBJ), which was also formed in incubations of 
human leukocytes with ionophore A231 87 and aracm- 
donic acid. The same compound has independently 
been isolated and characterized after stimulation of 
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human leukocyte suspensions with other agents 
(Jubiz et al. in preparation). 
Since the new leukotrienes were formed by u-oxi- 
dation of LTB+ they have probably retained the same 
configuration of the double bonds, i.e., 64s,&tmm, 
10-trans,l4_cis [t 21. Preliminary results show that 
SS,123,20-THETE can also be oxidized to a dicar- 
boxylic acid. Omega-oxidation to the dicarboxylic 
stage is a major pathway for metabolism of other 
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Fig.5. Scheme of transformation of arachidonic acid by preparations of human polymorphonuclear leukocytes. Dashed lines indi- 
cate proposed reactions. 
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is possible therefore, that w-hydroxylation and fur- 
ther oxidation to dioic acids represent important 
steps in leukotriene metabolism. 
This report shows that 20-OH-LTB4 and 20COOH- 
LTB4 largely retained the bronchoconstrictor activity 
of LTB+ However, although LTB4 is a potent bron- 
choconstrictor, it differs from the cysteinyl-contain- 
ing leukotrienes in being primarily a leukotactic agent 
and in causing leukocytes to adhere to the endothe- 
lium in postcapillary venules [22-241. 20-OH-LTB4 
and 20-COOH-LTB4 seem to be GO-times less potent 
than LTB4 in promoting leukocyte adhesion to endo- 
thelial cells in the hamster cheek pouch (Bjork et al. 
in preparation). Therefore it seems that w-oxidation 
of LTB4 has variable effects on different biological 
activities. The reason for this variability needs to be 
further investigated. 
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